National Cancer Institute, Naples clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 113 studies whose lead sponsor is National Cancer Institute, Naples. 39 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Keep track of what changes. Save the National Cancer Institute, Naples studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions National Cancer Institute, Naples leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 113. Browse all 113 →
- STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal CancerRecruitingNCT07213570Phase 2
- REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)RecruitingNCT07302451Phase 2
- Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.RecruitingNCT07577206Early Phase 1
- Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma PatientsRecruitingNCT05821556Phase 2
- Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With ImmunotherapyRecruitingNCT07213557Phase 2
- Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4Not yet recruitingNCT07522697Phase 2
- Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01RecruitingNCT07290894Phase 2
- Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom BurdenNot yet recruitingNCT07459920Phase 2
- Financial Toxicity in Patients With Early-stage Breast CancerRecruitingNCT07354165
- Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled TrialNot yet recruitingNCT07314853Not applicable
- Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.RecruitingNCT05817227
- The ONCOCAMP StudyRecruitingNCT06270602
- ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal CancerRecruitingNCT06714357Phase 2
- Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal CancerRecruitingNCT07269249
- Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.Not yet recruitingNCT07267780
- Application of da Vinci SP for Endometrial Cancer Surgical StagingRecruitingNCT07027046
- Identification of the Pathogenetic Mechanisms Underlying Squamous Cell CarcinomasRecruitingNCT06236464
- Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)RecruitingNCT04726228
- Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)RecruitingNCT06905262
- Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker AnalysisRecruitingNCT06905145
- Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial ToxicityRecruitingNCT06887244Not applicable
- Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)RecruitingNCT06894823
- Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial CancerRecruitingNCT06893861
- Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)RecruitingNCT06884878
- Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney DiseaseRecruitingNCT06886282
- Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer PatientsRecruitingNCT03874026Phase 2
- Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNomaRecruitingNCT06341764Phase 2
- PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)RecruitingNCT04854213Not applicable
- Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerRecruitingNCT06509126Phase 3
- A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)RecruitingNCT04893785Phase 2
- PRO for Fighting FT in Ovarian CancerRecruitingNCT06032975
- Prediction of True Oligo-metastatic Disease.RecruitingNCT05806151
- MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal CancerRecruitingNCT05233982Phase 2
- Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal CancerRecruitingNCT01651026
- Active Surveillance Versus Surgery in Thyroid Papillary MicrocarcinomaRecruitingNCT04129281Not applicable
- MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.RecruitingNCT05255471Phase 3
- Study on Gynecological Rare CancersRecruitingNCT05733806
- Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.RecruitingNCT05733793
- Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre ArchiveRecruitingNCT04290299
- A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)Active, not recruitingNCT06218511Phase 1
- "Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.Active, not recruitingNCT05818865Not applicable
- Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve EfficacyCompletedNCT03891485
- The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.Active, not recruitingNCT06866093
- MAnagement of METastatic Disease in Campania (MAMETIC)CompletedNCT04595032
- Multidisciplinary Integrated Platform for a Technological Innvovative Approach to OncotherapiesCompletedNCT05818020
- Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical CancerStatus unknownNCT00997009Phase 2
- Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal CancerStatus unknownNCT04310176Phase 2
- Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial CancerStatus unknownNCT03503786Phase 2
- Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free IntervalStatus unknownNCT00657878Phase 3
- Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and NeckStatus unknownNCT02624128Phase 2